8-K: Rennova Health Inks Deal to Exchange Two Subsidiaries for FOXO Stock, Secures Potential Controlling Stake

Rennova Health, Inc. has agreed to exchange its equity in two subsidiaries, Myrtle Recovery Centers and Rennova Community Health, for a combination of FOXO Technologies common and preferred stock, potentially making Rennova the controlling shareholder of FOXO.

Summary

• Rennova Health, Inc. has entered into two stock exchange agreements with FOXO Technologies, Inc.
• The first agreement involves Rennova exchanging its equity in Myrtle Recovery Centers for $500,000 worth of FOXO common stock.
• The number of FOXO shares issued was 2,173,913, calculated using a volume weighted average price of $0.23 per share.
• This transaction closed on June 14, 2024.
• The second agreement involves Rennova exchanging its equity in Rennova Community Health, which includes Big South Fork Medical Center, for $20 million of FOXO convertible preferred stock.
• Each share of the FOXO preferred stock has a stated value of $1,000.
• The closing of the Rennova Community Health transaction is subject to shareholder approvals and is expected in the third quarter of 2024.
• The purchase price for both transactions is subject to certain post-closing adjustments based on EBITDA.
• Rennova expects to monetize its FOXO stock over time.
• Preliminary unaudited estimates for RCHI and Myrtle for the year ended December 31, 2023, show net revenue of approximately $18.7 million and net income of approximately $5.2 million.

Sentiment

Score: 7

Explanation: The document presents a positive outlook for Rennova, highlighting potential benefits from the transactions, including improved access to capital and a potential controlling stake in FOXO. However, the reliance on stock and the need for shareholder approvals introduce some uncertainty, preventing a higher score.

Positives

• The transactions are expected to improve Rennova's access to capital.
• Rennova may become the controlling shareholder of FOXO upon closing of the Rennova Community Health transaction.
• Rennova expects to monetize its FOXO stock over time.
• The transactions provide a potential pathway for growth and expansion of the divested businesses.

Negatives

• The Rennova Community Health transaction is subject to shareholder approvals, which introduces uncertainty.
• The purchase price for both transactions is subject to post-closing adjustments based on EBITDA, which could impact the final value.
• The FOXO shares issued to Rennova are restricted securities and may only be resold in limited circumstances.

Risks

• The closing of the Rennova Community Health transaction is dependent on shareholder approvals.
• Post-closing adjustments to the purchase price based on EBITDA could affect the final value of the transactions.
• The value of FOXO stock could fluctuate, impacting the potential monetization for Rennova.
• There is a risk that the transactions may not close as expected or at all.

Future Outlook

Rennova expects to monetize its convertible preferred stock and common stock in FOXO over time and anticipates improved access to capital to facilitate growth and expansion of the divested businesses.

Management Comments

• Seamus Lagan, the Chief Executive Officer of Rennova, stated that the transactions have key tangible benefits to the Company.
• He also noted that the transactions will dramatically improve access to capital and, subject to the closing of the Rennova Community Health transaction, Rennova will be the controlling shareholder of FOXO.

Industry Context

This announcement reflects a trend of healthcare companies seeking strategic partnerships and acquisitions to enhance their financial position and expand their service offerings. The exchange of assets for stock is a common method for companies to achieve growth without immediate cash outlays.

Comparison to Industry Standards

• The valuation of Myrtle Recovery Centers at $500,000 is relatively low, suggesting it may be a smaller or less profitable operation compared to larger behavioral health providers.
• The $20 million valuation for Rennova Community Health, including a critical access hospital, is more substantial, but the value is tied to preferred stock in FOXO, which is subject to its own market conditions.
• Comparable transactions in the healthcare sector often involve a mix of cash and stock, with valuations based on multiples of revenue or EBITDA. The document does not provide enough detail to compare the valuation multiples to industry averages.
• The use of convertible preferred stock in the RCHI transaction is a common method for strategic investments, allowing for potential future equity upside while providing a degree of downside protection.
• The $2.5 million financing commitment for FOXO is relatively small compared to larger healthcare deals, indicating that FOXO may be a smaller company or in a turnaround situation.

Stakeholder Impact

• Shareholders of Rennova will need to approve the Rennova Community Health transaction.
• Shareholders of FOXO will need to approve the issuance of shares for both transactions.
• Employees of Myrtle and RCHI will transition to FOXO ownership.
• Customers of Myrtle and Big South Fork Medical Center will continue to receive services under new ownership.
• Creditors of Rennova may be impacted by the change in asset ownership.

Next Steps

• Rennova and FOXO will seek shareholder approvals for the Rennova Community Health transaction.
• FOXO will file a Supplemental Listing Application with the NYSE for the issuance of shares in the Myrtle transaction.
• Rennova will prepare audited financial statements for RCHI and Myrtle for filing by FOXO.
• The parties will work towards closing the Rennova Community Health transaction in the third quarter of 2024.

Key Dates

Keywords

stock exchange, acquisition, healthcare, hospital, behavioral health, FOXO Technologies, Rennova Health, Myrtle Recovery Centers, Rennova Community Health, Big South Fork Medical Center